4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004003
Chief Operating Officer sold 42,666 shares at $14.40 ($614,390)
- Chief Operating Officer acquired 12,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GIVEN BRUCE D · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-14 | Exercise or conversion : show line 1 in the form | +11,666 | $2.62 | $30,565 | 1,110,022 | D |
| 2019-01-14 | Exercise or conversion : show line 2 in the form | +1,000 | $6.20 | $6,200 | 1,111,022 | D |
| 2019-01-14 | Sale : show line 3 in the form | −42,666 | $14.40 | $614,390 | 1,068,356 | D |
| Open-market sales · 42,666 sh · avg $14.40 · $614,390 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-14 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −11,666 | 544,334 | D |
| 2019-01-14 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −1,000 | 543,334 | D |
Loading xslF345X03/doc4.xml…